Shen Zhi Ling oral liquid improve neuroinflammation against Alzheimer's disease via the PI3K/Akt pathway
- PMID: 39760003
- PMCID: PMC11695662
- DOI: 10.1007/s13205-024-04182-5
Shen Zhi Ling oral liquid improve neuroinflammation against Alzheimer's disease via the PI3K/Akt pathway
Abstract
The etiology and pathogenesis of Alzheimer's disease (AD) are complex, and currently, no comprehensive treatment measures exist. In this study, we initially utilized ultra-high-performance liquid chromatography with quadrupole orbitrap mass spectrometry (UHPLC-QE-MS) to profile the bioactive constituents of SZLOL present in the bloodstream. Subsequent Y-maze experimental data demonstrated that SZLOL could ameliorate short-term memory deficits in APP/PS1 mice. Furthermore, micro-positron emission tomography (Micro-PET) experiments revealed that SZLOL enhanced glucose metabolism in the cerebral cortex of the mice. To model AD in vitro, we utilized Aβ42-induced SH-SY5Y cells and assessed the effects of SZLOL-containing serum on cell growth and migration using immunofluorescence and wound-healing assays. Both in vivo and in vitro Western blot analyses indicated that SZLOL and SZLOL-containing serum were capable of activating the PI3K/Akt signaling pathway, which modulates the expression of inflammatory mediators. In future studies, we will validate our findings in more animal and cell models.
Keywords: Alzheimer’s disease; Autophagy; Neuroinflammation; PI3K/Akt pathway; Shen Zhi Ling oral liquid.
© King Abdulaziz City for Science and Technology 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests.
Similar articles
-
The Therapeutic Potential of Bombyx Batryticatus for Chronic Atrophic Gastritis Precancerous Lesions via the PI3K/AKT/mTOR Pathway Based on Network Pharmacology of Blood-Entering Components.Pharmaceuticals (Basel). 2025 May 25;18(6):791. doi: 10.3390/ph18060791. Pharmaceuticals (Basel). 2025. PMID: 40573188 Free PMC article.
-
The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer's disease.J Inflamm (Lond). 2025 Jun 23;22(1):25. doi: 10.1186/s12950-025-00449-7. J Inflamm (Lond). 2025. PMID: 40551105 Free PMC article.
-
Selegiline for Alzheimer's disease.Cochrane Database Syst Rev. 2003;(1):CD000442. doi: 10.1002/14651858.CD000442. Cochrane Database Syst Rev. 2003. PMID: 12535396
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
-
miR-410 Regulates Helper T Cell Differentiation in Ovalbumin-Induced Asthma through the PI3K-AKT-VEGF Signaling Pathway.Int Arch Allergy Immunol. 2024;185(1):1-9. doi: 10.1159/000531493. Epub 2023 Sep 19. Int Arch Allergy Immunol. 2024. PMID: 37725935
References
-
- Calsolaro V, Edison P (2016) Neuroinflammation in alzheimer’s disease: current evidence and future directions. AlzheimErs Dement 12(6):719–732 - PubMed
LinkOut - more resources
Full Text Sources